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Abstract
Background: Technique failure in peritoneal dialysis (PD) due to fibrosis and angiogenesis is complicated by
peritonitis. Staphylococcus aureus infection is one of the most common causes of peritonitis in PD. The heparan
sulfate proteoglycan, syndecan-1 (CD138), was reported to regulate fibrosis, angiogenesis, inflammation and S.
aureus infection. The objectives of this study were to examine the effects of syndecan-1 on S. aureus infection
and histopathology in a PD model.
Results: Syndecan-1-/- and wild type mice were dialyzed for 4 weeks and infected intraperitoneally with S. aureus.
Tissues were collected after 4 h for histomorphometric analysis. Intravital microscopy was used to observe leukocyte
recruitment and to quantify syndecan-1 in the parietal peritoneum microcirculation. The dialyzed syndecan-1-/-
mice were more susceptible to S. aureus infection than undialyzed syndecan-1-/- controls and wild type animals.
However, peritoneal fibrosis and neovascularization due to PD did not differ between syndecan-1-/- and wild type
mice. Intravital microscopy showed that in S. aureus infection, syndecan-1 was removed from the subendothelial
layer of peritoneal venules but syndecan-1 deficiency did not affect leukocyte recruitment.
Conclusions: This study indicates that, while syndecan-1 is important for providing a barrier to acute S. aureus
infection in PD, it does not affect peritoneal fibrosis and angiogenesis.
Keywords: Intravital microscopy, Leukocyte recruitment, Microcirculation, Fibrosis, Peritonitis, Proteoglycans
Background
Peritoneal dialysis (PD) is an effective replacement ther-
apy for chronic kidney failure. In PD, dialysis solution is
administered into the peritoneal cavity through a surgi-
cally implanted catheter and there is an exchange of
water and solutes between the patient’s blood and the
indwelling solution across the peritoneal membrane,
allowing for removal of excess water and wastes. How-
ever, PD failure typically occurs because of infection or
loss of ultrafiltration [1–3]. Underlying the loss of ultra-
filtration are deleterious alterations of the peritoneum
involving progressive fibrosis, angiogenesis, vasculopa-
thy, and phenotypic change of mesothelial cells of the
peritoneal membrane [4–6] to a fibroblast-like state, a
process referred to as epithelial-mesenchymal transition
(EMT). These deleterious alterations are further compli-
cated by bacterial peritonitis. The main site of infection
in PD is the lumen of the catheter from touch-
contamination as well as the outside of the catheter at
the exit site. Staphylococcus aureus, Staphylococcus epi-
dermidis, Pseudomonas aeruginosa and Escherichia coli
are among the most common microorganisms causing
peritonitis in PD [7–9].
The cell surface heparan sulfate proteoglycan, syndecan-
1 (Sdc1; CD138), modulates diverse processes such as
inflammation [10], wound repair [11], angiogenesis [12],
fibrosis [13], and EMT [14, 15]. Syndecan-1 is a single-
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pass type I transmembrane protein with several heparan
sulfate glycosaminoglycan chains covalently attached to
the distal portion of the extracellular domain. Syndecan-1
is expressed on mesothelial cells of the parietal periton-
eum, and in the subendothelial compartment of peritoneal
venules [16]. Some microbial pathogens subvert syndecan-
1 to increase dissemination and host defense evasion during
infection. Among the best-characterized pathogens that
manipulate syndecan-1 is S. aureus [17]. Although the role
of certain proteoglycans was examined in dialysis [18], the
role of syndecan-1 has not been investigated in PD. Given
that syndecan-1 regulates inflammation, fibrosis, angiogen-
esis and EMT, and syndecan-1-microbial interactions are
important in the pathogenesis of S. aureus, the aims of this
study were to characterize the effects of syndecan-1 defi-
ciency on peritoneal histopathology, foreign body reaction,
and S. aureus infection during subacute (4 weeks) PD. In
addition, we examined the effects of acute S. aureus infec-
tion on syndecan-1 protein expression in the peritoneal
microcirculation and its role in leukocyte recruitment.
Methods
Animals
The animal protocols met the regulations set by the
Canadian Council of Animal Care and were approved by
the McMaster University Animal Research Ethics Board
(Animal Utilization Protocol #11-01-03). All animal
protocols followed the “Animal research: reporting of
in vivo experiments” guidelines [19]. Six- to 8-week-
old male BALB/c mice were obtained from Taconic
(Germantown, NY, USA) and given at least 1 week
to acclimatize in a specific pathogen-free facility.
These mice were verified to be S. aureus-free by the
supplier. The age-matched syndecan-1 null (Sdc1-/-)
male mice used in this study were on a BALB/c
background and sourced from a colony that was
interbred and maintained at McMaster University
Central Animal Facility. The Sdc1-/- breeders, which
tested negative for S. aureus, were a kind gift from Dr.
Pyong W. Park (Children’s Hospital, Harvard Medical
School, Boston, MA, USA). Syndecan-1 deficiency in the
mouse colony was confirmed using in vivo imaging of the
parietal peritoneum microcirculation with immunofluor-
escence [16].
Nonuremic subacute peritoneal dialysis model
Detailed methods were previously described [20]. Sterile
silicone catheters (inner diameter (ID) 0.635 mm, outer
diameter (OD) 1.1938 mm) attached to silicone injection
ports (Penny MousePort™; Access Technologies, Skokie,
IL, USA) were aseptically implanted subcutaneously into
wild type and Sdc1-/- mice under gaseous anesthesia. Be-
fore insertion, the port and catheter were flushed with
10 % heparin (1000 USP Units mL-1; Sandoz Canada
Inc., Boucherville, QC, Canada) to maintain patency.
The 1-cm tip of the catheter was inserted through the
right lower quadrant of the abdominal wall into the peri-
toneal cavity. One week after catheter implantation,
10 % heparin solution was injected into the port to keep
the catheter patent. The mice were given 2 weeks to
acclimatize to the implant. After the acclimatization
period, daily 2-mL injections of a conventional lactate-
buffered dialysis solution (Dianeal PD4 CAPD Solution
with 2.5 % [w/v] dextrose and 2.5 mEq L-1 calcium, ap-
proximate pH 5.2; Baxter, Mississauga, ON, Canada)
were administered into the Penny MousePort™ for 4
weeks. The skin over the port was sterilized and
injections were performed using aseptic technique in a
biological safety cabinet.
Bacterial strain and growth conditions
S. aureus H1559 cultures were grown overnight on a
shaker in tryptic soy broth (TSB) (EMD, Darmstadt,
Germany) plus 15 μg mL-1 of erythromycin (Sigma-Al-
drich®, St. Louis, MO, USA) to select for a green fluores-
cent protein (GFP)-expressing plasmid, constitutively
expressed from the prsA promoter cloned into pCN56
[21]. The overnight cultures were diluted 100-fold in
fresh TSB and grown for 2.5 h at 37 °C to an optical
density of ~0.5 at 600 nm. The subcultures were sedi-
mented, washed and suspended in 100 μL of sterile 1X
phosphate-buffered saline (PBS; pH 7.2, 0.14 M NaCl,
2.7 mM KCl, 0.88 mM KH2PO4, 6.4 mM Na2HPO4 ·
7H2O). Colony-forming units (CFU) were enumerated
following serial dilutions and plating on tryptic soy agar
(TSA) plates with 10 μg mL-1 erythromycin (Teknova,
Hollister, CA, USA). The inocula contained approxi-
mately 1.8 × 108 CFU.
S. aureus infection and tissue collection
On the last day of the 4-week dialysis period, mice re-
ceived an injection of S. aureus into the subcutaneous
port, which was immediately followed by an injection of
2 mL of dialysis solution through the port. The infected
non-PD controls were wild type and Sdc1-/- animals that
did not undergo dialysis and were injected intraperitone-
ally (IP) on the right side with an equivalent amount of
S. aureus suspension. After 4 h, wild type and Sdc1-/-
mice were anesthetized with a subcutaneous injection of
a mixture of ketamine (200 mg kg-1) and xylazine (10
mg kg-1). Under sterile conditions, peritoneal lavage was
performed with 2 mL of PBS. The intra-abdominal por-
tion of the PD catheter was retrieved and fixed in 2 %
[v/v] glutaraldehyde in sodium cacodylate. Samples of
the anterior abdominal wall from dialyzed animals were
collected in a standardized manner from the left upper
quadrant, adjacent to the midline and contralateral to
the catheter insertion site. This position was above the
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region that contacted the intra-abdominal catheter tip.
For the undialyzed animals that received a suspension of
S. aureus with an IP needle injection, the section of
abdominal wall sampled was contralateral and superior
to the injection site. Anatomically matching areas were
extracted for baseline histology. The samples were fixed
in 10 % [v/v] buffered formalin. Additional samples of
the anterior abdominal wall, taken from the left lower
quadrant, were homogenized. Blood was collected via
cardiac puncture. Euthanasia was ensured by cervical
dislocation.
Colony-forming units from the peritoneal lavage fluid,
blood and abdominal wall homogenate were enumerated
after serial dilutions and plating on TSA plates with 10
μg mL-1 erythromycin. The peritoneal lavage fluid and
blood were mixed with 3 % [v/v] acetic acid (Caledon
Laboratory Chemicals, Georgetown, ON, Canada) and
1 % [w/v] crystal violet (Sigma-Aldrich®) in a 5:44:1 ratio.
Blood cell counts with a hemacytometer were averaged
from 6 separate samples of the mixture of blood or
lavage fluid. Differential white blood cell counts were
performed on smears of blood fixed in methanol and
stained with eosin and thiazine (Harleco Hemacolor®
stain set; EMD Chemicals, Gibbstown, NJ, USA). Results
were compared with baseline levels in wild type and
Sdc1-/- mice that did not undergo PD and were not in-
fected. In total, 6 groups were observed, with n = 8 mice
in the wild type and Sdc1-/- baseline groups as well as
the Sdc1-/- infected non-PD group and Sdc1-/- infected
PD group. The wild type infected non-PD and infected
PD groups both had 14 mice.
Scanning electron microscopy
The catheter pieces were immersed for 2 h in primary
fixative solution (2 % [v/v] glutaraldehyde in 0.1 M so-
dium cacodylate buffer at pH 7.4). The samples were
rinsed twice in buffer solution and post-fixed for 1 h in
1 % [w/v] osmium tetroxide in 0.1 M sodium cacodylate
buffer. After the second fixation step, the samples were
dehydrated through a graded ethanol series and then
dried in a critical point dryer. After drying, the catheter
pieces were cut open to expose the inner surface of the
catheters and mounted onto scanning electron micros-
copy stubs. The stubs were sputter coated with gold and
viewed with a Tescan Vega II LSU scanning electron
microscope (Tescan USA, Cranberry TWP, PA, USA)
operating at 20 kV. Image acquisition was performed
with Tescan VegaTC operating software (Tescan USA,
Cranberry TWP, PA, USA).
Histopathologic examination
The formalin-fixed tissue samples were embedded in par-
affin and thin-sectioned. The cross-sections were stained
with hematoxylin and eosin (H&E) (Sigma-Aldrich®) or
picro-sirius red (abcam®, Cambridge, MA, USA) for
visualization of collagen. For identification of elastic fibers,
cross-sections were stained with resorcin-fuchsin and
counterstained in van Gieson’s solution and Weigert’s iron
hematoxylin (Electron Microscopy Sciences, Hatfield, PA,
USA). Microscopic examination was performed using an
Olympus BX41 microscope with an Olympus DP72® cam-
era (Olympus America Inc., Center Valley, PA, USA) and
acquired using SlideBook 5.0 custom-built microscopy
software (Intelligent Imaging Innovations, Inc., Denver,
Co, USA). Peritoneal thickness was measured at five ran-
dom locations in each H&E-stained section and averaged,
and the number of peritoneum-associated blood vessels
was counted along the entire length of the section of peri-
toneum and recorded as vessels per mm of peritoneum.
The blood vessel counts were verified using immunohisto-
chemical staining of the paraffin-embedded tissues with a
monoclonal antibody to the cell surface marker platelet
endothelial cell adhesion molecule-1 (PECAM-1; CD31).
Immunohistochemistry
Paraffin sections were placed on a slide and deparaffi-
nised, hydrated and heated in citrate buffer in prepar-
ation for immunohistochemistry (IHC). After quenching
endogenous peroxidase activity and blocking with nor-
mal goat serum, the sections were incubated with rat
anti-mouse F4/80 monoclonal antibody (clone CI:A3-1;
Santa Cruz Biotechnology, Inc., Dallas, Texas, USA) or
isotype control antibody (rat IgG2b, clone 141945; R&D
Systems®, Inc., Minneapolis, MN, USA) for 48 h at 4 °C.
Biotinylated goat anti-rat secondary antibody was used
to detect the primary antibody and visualized using the
ABC system with 3,3′-diaminobenzidine (DAB) as the
chromogen (ImmunoCruz™ Rat ABC Staining System;
Santa Cruz Biotechnology, Inc.). The sections were coun-
terstained with Gill’s hematoxylin solution No. 2 (Santa
Cruz Biotechnology, Inc.). Microscopic examination of
macrophages in the peritoneal tissue was performed using
an Olympus BX41 microscope. The ImmunoCruz™ Rat
ABC Staining System was also used for immunohisto-
chemical staining of blood vessels using rat anti-mouse
PECAM-1/CD31 monoclonal antibody (clone RM0032-
1D12; Santa Cruz Biotechnology, Inc.).
Preparation for intravital microscopy
For all intravital microscopy (IVM) experiments, a new
set of animals was used that was not treated with PD.
The detailed methods on the surgical preparation for
IVM were previously described [16]. Briefly, animals
were anesthetized (ketamine and xylazine) and the right
internal jugular vein was cannulated with a polyethylene
catheter (ID 0.28 mm, OD 0.61 mm, Intramedic™,
Becton, Dickinson and Company, Mississauga, ON,
Canada) for maintenance of anesthesia, administration
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of fluids or fluorescent antibodies. Skin was bluntly
dissected away and a midline incision along the linea
alba was made in the abdominal wall extending infer-
iorly from the xiphoid process towards the left in-
guinal region. The animals were placed in the right
lateral position and the peritoneum on the left side of
the abdominal wall was laid out on a microscope
stage and covered with plastic wrap to prevent evap-
orative loss.
Spinning disk confocal intravital microscopy
Wild type mice were injected IP with S. aureus lipotei-
choic acid (LTA) (125 μg; Sigma-Aldrich®) or a 100 μL
suspension of GFP-expressing S. aureus cells containing
approximately 1.8 × 108 CFU (n = 4 mice). After 4 h, the
mice were prepared for IVM of the parietal peritoneum
microcirculation and injected intravenously (IV) with
Alexa Fluor® 568-labeled rat anti-mouse syndecan-1
ectodomain antibody (40 μg, clone 300506; R&D Systems®,
Inc.). The peritoneal microcirculation was visualized with a
spinning disc confocal system (Leica DMI 6000 B; Leica
Microsystems, Mannheim, Germany) based on a Yokogawa
spinning disc confocal unit, spectral laser merge module
LMM5, and Hamamatsu back-thinned electron multiplying
charge-coupled device C9100-12 camera (Hamamatsu,
Hamamatsu City, Japan). During the IVM observations, the
animals were placed in a chamber mounted on the confocal
microscope and the temperature in the chamber was set to
37 °C. The peritoneal microcirculation was observed with a
40× objective lens and images were acquired using the
Volocity® 4 acquisition software (Improvision, Waltham,
MA, USA).
Quantification of fluorescence intensity
Using ImageJ (National Institutes of Health, W. Rasband,
Bethesda, Maryland, USA), the fluorescence intensity of
the Alexa Fluor® 568-conjugated anti-syndecan-1 anti-
bodies was quantified from the captured in vivo images of
peritoneal venules. The fluorescence intensity of the la-
beled antibodies was measured along the length of the
basolateral side of the venular endothelium and the value
for the corresponding intravascular fluorescence intensity
was subtracted. This relative difference in intensity was
calculated for 4 venules per mouse and the values were re-
corded as the difference in mean fluorescence intensity
(arbitrary fluorescence units).
Transillumination intravital microscopy
Wild type and Sdc1-/- mice were injected IP with ap-
proximately 1.8 × 108 CFU of S. aureus (100 μL), while
clinical grade saline (0.9 % [w/v] NaCl) was injected IP
into control animals (n = 4 mice). All IP injections were
performed on the right side. The microcirculation
underlying the parietal peritoneum on the left side of
the abdominal wall was observed using an inverted in-
travital microscope (Zeiss Inverted Axiovert 100; Carl
Zeiss, Jena, Germany). The tissue was transilluminated
with a light source via fiberoptic (The ACE® Series;
Schott-Fostec, LLC, Auburn, NY, USA) equipped with a
150 Watt tungsten halogen lamp. Images were captured
with an attached camera (Newvicon; DAGE-MTI,
Michigan City, IN, USA), projected onto a monitor
(Panasonic, CT-2086YD; Panasonic Canada Inc., Missis-
sauga, ON, Canada) and recorded with a DVD recorder
(Panasonic, DMR-EH55) for offline analysis. The animals
were warmed with an infrared heat lamp positioned over
the microscope during the intravital observations. To
minimize effects of tissue exposure during IVM [22], ob-
servations were made within 10 min after completion of
surgical preparation. Euthanasia was performed by cer-
vical dislocation under deep anesthesia.
Offline analysis
Leukocyte-endothelial cell interactions were quantified
in 4–6 venules per mouse. Rolling leukocytes, consid-
ered as cells tethering to a venule with torsional motion,
were counted per minute. Intravascular leukocytes that
remained stationary for at least 30 s were identified as
adherent cells and perivenular leukocytes were counted
as extravascular cells on a field of view measuring 180
μm× 135 μm.
Statistical analysis
Data are expressed as mean ± standard error of the mean
(SEM). Statistical significance was set at p < 0.05 and cal-
culated using Student’s t-test or ANOVA with Bonfer-
roni correction using the computer software package
KaleidaGraph 3.6 (Synergy Software, Reading, PA, USA).
Results
Animal characteristics
Following catheter implantation surgery, there were no
significant changes in behavior or appearance of the ani-
mals and skin incisions healed well, with no signs of in-
fection. One mouse in the Sdc1-/- group was euthanized
at the end of the catheter acclimatization period because
of fighting injuries from the cage mate. There were no
differences in the weights of the animals between the
wild type group and Sdc1-/- group at the start (26.93 ±
0.30 g versus 25.88 ± 0.55 g, respectively) and end
(30.50 ± 0.42 g versus 29.13 ± 0.44 g, respectively) of
the experiment. Upon midline laparotomy, 1/14 wild
type mice had omental wrapping of the catheter at
the entry site on the abdominal wall, and 8/14 wild
type mice and 5/8 Sdc1-/- mice had gonadal adipose
tissue wrapping at catheter entry site with no occlu-
sion of the catheter tip.
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Sdc1-/- mice have higher S. aureus loads in the abdominal
wall after peritoneal dialysis
To determine whether subacute exposure to PD and lack
of syndecan-1 affect the progression of S. aureus peri-
toneal infection, wild type and Sdc1-/- mice were infected
through the peritoneal catheter, while control animals
were infected through a needle injection IP. Four hours
post-infection, peritoneal lavage fluid, blood and a sam-
ple of the left abdominal wall were collected for CFU
enumeration. There were no significant differences in
the CFU counts from the peritoneal lavage between dia-
lyzed animals and non-dialysis controls, or wild type and
Sdc1-/- mice (Fig. 1a). There were also no differences in
CFU counts from blood samples between any of the
groups (Fig. 1b). An outlier was excluded from the
Sdc1-/- PD group because the value was far beyond the
range of values calculated by subtraction and addition of
1.5 times the interquartile range to the first and third
quartile. Contamination during cardiac puncture was
strongly suspected. Nevertheless, ANOVA tests with
Bonferroni correction did not show any significant dif-
ference between the groups with and without the inclu-
sion of the outlier. The bacterial counts from the blood
suggested sepsis in some animals, which was accompan-
ied by diarrhea and slower movement. The CFU counts
from the abdominal wall homogenate samples were sig-
nificantly increased in the Sdc1-/- animals, but only in
the group that was treated with PD (Fig. 1c). These
results indicate that the parietal peritoneum and the
underlying tissues of Sdc1-/- mice are more susceptible
to S. aureus invasion in the context of PD-induced
injury.
All of the infected animals had a significantly increased
number of peritoneal leukocytes compared with baseline
levels (Table 1). Although the peritoneal leukocyte counts
were reduced in the Sdc1-/- animals with S. aureus infec-
tion compared with wild type, the difference was not
statistically significant. Systemic white blood cell counts
did not significantly differ between the groups; however,
the number of systemic neutrophils was significantly de-
creased in the dialyzed wild type animals compared with
non-PD controls. Also, the number of systemic monocytes
was significantly elevated in wild type non-PD animals
with S. aureus infection compared with Sdc1-/- mice and
baseline controls.
Host material deposition in the peritoneal catheters of
Sdc1-/- and wild type mice
Foreign body reactions are characterized by macrophage
adherence to implants and fusion to form foreign body
giant cells [23]. In vitro work showed that Sdc1-/- macro-
phages have impaired motility [24]. Thus, foreign body
reactions to the catheter implant were examined using
scanning electron microscopy after 4 h of S. aureus
infection. Leukocytes, platelets and crenated red blood
cells were recruited to the catheter lumen (Fig. 2a).
Leukocytes reacted to the foreign body by attachment to
the surface within a fibrin network (Fig. 2b). These in-
cluded macrophages and neutrophils that appeared to
communicate through cell surface extensions. The in-
flammatory cells interacted with S. aureus microcolonies
Fig. 1 Sdc1-/- mice have higher S. aureus loads in the abdominal
wall after peritoneal dialysis (PD). Viable bacteria counts from (a)
lavage samples, (b) blood and (c) abdominal wall homogenates
from wild type and Sdc1-/- mice collected 4 h after the animals were
injected with 1.8 × 108 colony-forming units (CFU) of S. aureus
through the peritoneal catheter (PD group) or with an intraperito-
neal needle injection (non-PD group). Data recorded as mean ± SEM,
analyzed with ANOVA with Bonferroni correction and expressed as
Log10 CFU per mL of peritoneal fluid or blood, or g of tissue, n = 14
mice in the wild type infected non-PD group and wild type PD
group, n = 8 mice in all other groups, *p < 0.01 compared with all
other groups. Sdc1-/- mice that were dialyzed for 4 weeks had a
significantly higher number of viable bacterial cells in the abdominal
wall samples after 4 h of infection
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(Fig. 2c). The results suggest that syndecan-1 defi-
ciency does not alter the recruitment of inflammatory
cells to a foreign body.
Syndecan-1 deficiency does not affect histopathologic
changes of the peritoneum in subacute peritoneal dialysis
Baseline control animals had an intact mesothelial sur-
face (Fig. 3a) and non-PD mice that received an IP injec-
tion of S. aureus did not exhibit mesothelial disruption
(Fig. 3b). Mice that were treated with PD, however, had
a thickened peritoneum, with increased vascularization,
interstitial hypercellularity, and leukocyte infiltration
(Fig. 3c). The average thickness of the peritoneal layer
was significantly increased in the PD groups (Fig. 4a),
which suggests fibrosis. However, there was no signifi-
cant difference between Sdc1-/- mice and wild type ani-
mals. The number of peritoneum-associated vessels was
significantly increased in dialyzed animals compared
with non-PD controls but did not differ between the
Sdc1-/- mice and wild type animals (Fig. 4b). These blood
vessel counts were verified with immunohistochemically-
stained paraffin sections with anti-PECAM-1/CD31 and
were found to be similar between the two methods (data
not shown). Increased collagen deposition is characteristic
of fibrosis. Extensive and disorganized collagen deposition
was observed in the thickened peritoneal layer of dialyzed
animals (Fig. 5) in both wild type and Sdc1-/- mice. While
the submesothelial layer of elastic fibers was near the
mesothelial surface in undialyzed animals (Fig. 6a), it was
several cell layers below the surface in the dialyzed wild
type and Sdc1-/- mice (Fig. 6b-d). Macrophages are a
source of profibrotic molecules [25]. In the parietal peri-
toneum, depletion of macrophages was associated with
decreased fibrosis in a mouse model of PD [26]. Thus, the
presence of macrophages in the fibrotic peritoneal tissue
was detected with IHC using F4/80, a cell surface marker
for mature macrophages in mice. With the immunohisto-
chemical analysis, F4/80+ cells were not detected in the in-
fected non-PD control animals, but were found to be
concentrated near the peritoneal surface in the dialyzed
Table 1 Peritoneal lavage leukocyte counts and differential blood leukocyte counts
Treatment/strain Total peritoneal cells × 106 Total blood cells × 109 L-1 Blood neutrophils Blood lymphocytes Blood monocytes
Baseline wild type 3.52 ± 0.43 4.08 ± 0.67 0.99 ± 0.27 3.06 ± 0.42 0.04 ± 0.01**
Baseline Sdc1-/- 2.78 ± 0.28 4.56 ± 0.68 1.14 ± 0.26 3.40 ± 0.51 0.02 ± 0.01
Non-PD + S. aureus wild type 25.78 ± 3.43*** 4.98 ± 0.65 1.80 ± 0.20 3.14 ± 0.53 0.34 ± 0.07
Non-PD + S. aureus Sdc1-/- 15.94 ± 1.57*** 3.62 ± 0.49 1.58 ± 0.31 2.01 ± 0.25 0.03 ± 0.02**
PD + S. aureus wild type 31.65 ± 1.90*** 3.12 ± 0.33 0.79 ± 0.12* 2.14 ± 0.27 0.19 ± 0.04
PD + S. aureus Sdc1-/- 22.42 ± 1.89*** 3.29 ± 0.52 1.05 ± 0.16 2.11 ± 0.41 0.13 ± 0.03
At the end of the peritoneal dialysis (PD) period, mice were infected intraperitoneally with 1.8 × 108 colony-forming units of S. aureus and 4 h after, peritoneal
lavage was performed and blood was collected via cardiac puncture for enumeration of leukocytes. Data recorded as mean ± SEM and analyzed with ANOVA
with Bonferroni correction, 6 counts averaged per mouse, n = 8–14 mice, *p < 0.01 and **p < 0.001 compared with non-PD wild type infected mice, ***p < 0.0001
compared with baseline values. S. aureus-infected mice had significantly increased numbers of peritoneal leukocytes compared with baseline but systemic
leukocyte counts did not differ significantly
Fig. 2 Host reaction to the peritoneal dialysis catheters. After 4
weeks of peritoneal dialysis, the intra-abdominal portion of the peritoneal
catheter was collected from wild type and Sdc1-/- mice that were
injected with S. aureus through the catheter. The catheters were fixed
and prepared for scanning electron microscopy after 4 h of S. aureus
infection. a Leukocytes and clotting components were recruited to the
lumen of the catheter. Leukocytes were seen interacting with (b) other
leukocytes and (c) S. aureus (arrows). Host responses to the biomaterial
were similar in Sdc1-/- and wild type mice
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wild type and Sdc1-/- animals in some areas of the sections
(Fig. 7a). The adjacent sections that were incubated with
the isotype control antibodies had no significant back-
ground signal (Fig. 7b). Taken together, these findings
suggest that syndecan-1 is not a major modulator of mor-
phological changes due to fibrosis and angiogenesis in
PD-induced histopathology.
S. aureus infection decreases subendothelial syndecan-1
in the peritoneal venules
To examine the effects of S. aureus infection on
syndecan-1 levels in the peritoneal microcirculation,
fluorescence IVM was performed on wild type mice that
were injected IP with S. aureus LTA or GFP-expressing
S. aureus and, after 4 h, the mice were injected IV with
Alexa Fluor® 568-labeled anti-syndecan-1. During LTA-
induced sterile inflammation, anti-syndecan-1 was de-
tected on the subendothelial side of peritoneal venules
(Fig. 8a). With S. aureus infection, however, anti-syndecan-
1 antibody did not label peritoneal venules (Fig. 8b), as
shown by quantification of fluorescence intensity from the
anti-syndecan-1 antibodies on venules in LTA-injected and
S. aureus-infected mice (Fig. 8c). The GFP-expressing S.
aureus cells were not visible against the tissue background
(Fig. 8b). These findings indicate that S. aureus infection
decreased syndecan-1 protein levels in the subendothelial
region of peritoneal venules.
Syndecan-1 does not modulate leukocyte recruitment to
the parietal peritoneum microcirculation during S. aureus
infection
To investigate whether syndecan-1 deficiency alters
leukocyte recruitment during S. aureus infection, wild
type and Sdc1-/- mice were injected with a suspension of
S. aureus IP and prepared for IVM after 4 h. Control
mice were injected IP with sterile saline. Numbers of
Fig. 3 Severe peritoneal pathology in wild type and Sdc1-/- mice
with subacute peritoneal dialysis. At the study endpoint, samples of
the abdominal wall were collected from (a) wild type and Sdc1-/-
mice that served as baseline controls, (b) wild type and Sdc1-/- mice
that were injected with S. aureus intraperitoneally and (c) mice that
were treated with peritoneal dialysis for 4 weeks and infected with
S. aureus for 4 h. The samples were fixed, sectioned and stained with
hematoxylin and eosin for histopathologic analysis. The peritoneal
layer of dialyzed mice was thickened and is seen spanning the
entire field of view. Red lines indicate boundaries of the peritoneal
layer. Insets show increased vascularization of the submesothelial
zone in dialyzed samples. Representative images, n = 14 mice in the
wild type infected non-PD group and wild type PD group, n = 8
mice in all other groups, scale bar = 100 μm
Fig. 4 Wild type and Sdc1-/- mice exhibit similar levels of fibrosis
and neovascularization during subacute peritoneal dialysis (PD). The
(a) thickness and (b) vascular density of the peritoneal layer were
quantified from the hematoxylin and eosin-stained sections. Data
recorded as mean ± SEM and analyzed with ANOVA with Bonferroni
correction, n = 14 mice in the wild type groups and n = 8 mice in
the Sdc1-/- groups, *p < 0.01 and ***p < 0.0001 compared with
controls that were not treated with peritoneal dialysis (non-PD).
There were no differences in the levels of fibrosis and vascularization
in the peritoneal layer of wild type and Sdc1-/- mice
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rolling leukocytes in mice infected with S. aureus were
similar to saline controls (Fig. 9a). The number of adher-
ent (Fig. 9b) and extravascular (Fig. 9c) leukocytes was
significantly increased in S. aureus infection. However,
there were no significant differences in the numbers of
rolling, adherent and extravascular leukocytes between
wild type and Sdc1-/- mice. Thus, syndecan-1 does not
modulate leukocyte trafficking in peritoneal venules dur-
ing S. aureus infection.
Discussion
Sdc1-/- mice were reported to have abnormal phenotypes
in injury and infection models [11, 17, 27–29]. In this
study, we examined whether the abnormal phenotypes
associated with syndecan-1 deficiency occur in PD. We
observed that histopathologic alterations of the periton-
eum did not differ between Sdc1-/- and wild type mice.
However, Sdc1-/- mice were more susceptible to S. aur-
eus infection, but only in the context of PD and despite
Fig. 5 Extensive collagen deposition in wild type and Sdc1-/- mice
with subacute peritoneal dialysis. At the study endpoint, samples of
the abdominal wall were taken from (a) baseline control mice, (b)
undialyzed animals that were injected with S. aureus and (c) mice
that were treated with peritoneal dialysis for 4 weeks and infected
with S. aureus 4 h before the endpoint. The sections were stained
with picro-sirius red to visualize collagen fibers. The thickened
peritoneal layer of dialyzed mice was rich in collagen fibers that were
disorganized in both, the wild type and Sdc1-/- mice. Representative
images, n = 14 mice in the wild type infected non-PD group and wild
type PD group, n = 8 mice in all other groups, (a & b) scale bar = 50
μm and (c) scale bar = 100 μm
Fig. 6 Similar changes in elastic tissue in wild type and Sdc1-/- mice with
subacute peritoneal dialysis. Sections of the abdominal wall from (a) S.
aureus-infected undialyzed control mice and (b) S. aureus-infected
animals that were treated with peritoneal dialysis for 4 weeks were
stained with resorcin-fuchsin and counterstained with van Gieson’s
solution and Weigert’s iron hematoxylin to identify elastic fibers
(indicated by arrows). a The network of elastic fibers was near
the mesothelial surface in the undialyzed animals but was far
below the mesothelial surface in the (c) dialyzed wild type and
Sdc1-/- animals. d Elastic fibers were not observed near the
mesothelial surface in the dialyzed animals. Representative images,
n = 14 mice in the wild type groups and n = 8 mice in the Sdc1-/-
groups, (a, c & d) scale bar = 50 μm and (b) scale bar = 100 μm
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the fact that syndecan-1 deficiency did not affect leukocyte
trafficking in S. aureus peritonitis. Thus, although
syndecan-1 did not affect histopathology in PD, it was
important for decreasing S. aureus dissemination.
Our observation that Sdc1-/- mice were more suscep-
tible to S. aureus colonization of the abdominal wall
after 4 weeks of PD contrast with findings in the corneal
tissue, where Sdc1-/- mice cleared S. aureus infection
more effectively while S. aureus induced syndecan-1
shedding from the corneal epithelium in wild type ani-
mals [17]. Other studies also found protective effects of
syndecan-1 deficiency during infections. Syndecan-1 de-
ficiency protected mice in P. aeruginosa lung infection
[30], and this pathogen was also found to promote
syndecan-1 shedding. As well, Sdc1-/- mice had decreased
mortality, less systemic bacterial dissemination and de-
creased cytokine production compared with wild type ani-
mals in a burn-wound model with P. aeruginosa infection
[31]. One difference, however, is that these studies used
injury models that are acute in nature, whereas our study
involved 6-week exposure to a peritoneal catheter and 4-
week exposure to dialysis solution. Perhaps the ability of
pathogens such as S. aureus to subvert syndecan-1 shed-
ding to enhance pathogenesis is decreased in longer injury
models. This idea raises the question whether Sdc1-/- mice
in this long-term injury model would have similarly in-
creased susceptibility to other pathogens, such as P.
aeruginosa, during an acute peritoneal infection. Given
that P. aeruginosa infection in syndecan-1 deficiency
results in attenuated pro-inflammatory cytokine re-
sponses [31], it is plausible that increased susceptibility
to this pathogen would also be observed in the Sdc1-/-
mice with the subacute PD model during the first 4 h
of infection where pro-inflammatory cytokines orches-
trate the innate immune response to pathogen invasion.
The cytoplasmic domain of syndecan-1 binds cytoskel-
etal proteins and PDZ-domain proteins and, conse-
quently, regulates remodelling of the actin cytoskeleton
[32]. Syndecan-1 also mediates cell adhesion through its
effects on integrins [33]. Not surprisingly, syndecan-1
deficiency was reported to impair epithelial barriers in in-
jury and inflammation. After corneal wounding, Sdc1-/-
mice had decreased re-epithelialization, reduced α9-integ-
rin localization and failure of apical repolarization of the
tight junction protein zonula occludens (ZO)-1 [11]. Also,
Sdc1-/- mice had decreased intestinal epithelial barrier
function resulting in increased intestinal protein leakage, a
finding that was replicated in human epithelium in vitro
Fig. 7 Macrophages concentrate near the peritoneal surface in wild type and Sdc1-/- mice with subacute peritoneal dialysis. Sections of the
abdominal wall from S. aureus-infected animals that were treated with peritoneal dialysis for 4 weeks were prepared for immunohistochemistry
and incubated with (a) anti-F4/80 antibody to identify macrophages or (b) the isotype control antibody and counterstained with Gill’s hematoxylin No.
2. In some areas of the sections, F4/80+ cells were found in the fibrotic peritoneum concentrated near the surface (brown color).
Representative images, n = 4 mice, scale bar = 50 μm
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[34]. Disruption of epithelial barriers is important in S.
aureus pathogenesis. For example, in human airway epi-
thelium, S. aureus caused disruption of actin and ZO-1
[35]. In this study, S. aureus activated proteolysis of
junctional proteins to alter the epithelial barrier for transe-
pithelial invasion. In human intestinal epithelium, S.
aureus α-toxin disrupted the barrier integrity with a re-
duction of cellular junctional proteins, namely ZO-1, ZO-
3 and E-cadherin [36]. Thus, another possibility is that the
mesothelial layer of the Sdc1-/- mice in our study was
more easily breached by S. aureus, resulting in increased
invasion of the abdominal wall with subacute PD-induced
injury. As well, given that decreased epithelial integrity
mediates pathogen invasion in wounds, it is plausible that
syndecan-1 deficiency during PD-induced injury would
also lead to increased susceptibility to other pathogens
such as P. aeruginosa, a common cause of wound infec-
tions [37].
Although syndecan-1 was shown to be involved in
angiogenesis, in that Sdc1-/- mice exhibited increased
corneal neovascularization in an angiogenesis assay [28]
and syndecan-1 overexpression promoted tumor angio-
genesis [12], we found that the increased vessel density
in dialyzed animals was similar between Sdc1-/- and wild
type mice. Furthermore, we found no evidence that fi-
brotic responses and collagen organization were altered
in dialyzed Sdc1-/- mice compared with wild type, even
though altered phenotypes were noted by others in
fibrotic mouse models. For example, in a mouse model
of myocardial infarction, Sdc1-/- mice had elevated
leukocyte recruitment and increased matrix metallopro-
teinase activity with increased collagen fragmentation
and disorganization [29]. This phenotype also involved
increased cardiac dilation and dysfunction. In an angio-
tensin II-induced cardiac fibrosis mouse model, however,
Sdc1-/- mice exhibited less cardiac fibrosis with de-
creased expression of collagen type I and III and reduced
cardiac dysfunction [13]. Thus, the effects of syndecan-1
deficiency differ based on the fibrosis model. In trans-
forming growth factor-β1-induced peritoneal fibrosis, a
secondary basement membrane was formed near the
mesothelial surface, while remnants of the original base-
ment membrane were found 50 to 100 μm below the
mesothelial surface in the rat peritoneum [38]. The peri-
toneal basement membrane is lined by a network of
elastic fibers [39]. Our findings show that while the ori-
ginal layer of elastic fibers was several cell layers below
the surface, a new network of elastic fibers was not
formed near the mesothelial surface in PD, and this fi-
brotic response was not affected by syndecan-1 defi-
ciency. As well, Sdc1-/- and wild type mice both had
heterogeneous distribution of macrophages in the fi-
brotic tissue that were mostly concentrated near the
peritoneal surface. Peritoneal fibrosis in PD models was
shown to be largely due to a foreign body reaction to the
catheter implant that contained a sterile cell layer of red
Fig. 8 S. aureus infection decreases subendothelial syndecan-1 levels of the peritoneal venules. Wild type mice were injected intraperitoneally
with (a) 125 μg of lipoteichoic acid (LTA) from S. aureus or (b) 1.8 × 108 colony-forming units of green fluorescent protein (GFP)-expressing S.
aureus. After 4 h, the mice were prepared for fluorescence intravital microscopy and Alexa Fluor® 568-labeled anti-syndecan-1 antibodies were
injected intravenously. The microcirculation of the parietal peritoneum was examined. Syndecan-1 was detected in the subendothelial compartment of
venules in (a) LTA-stimulated mice (arrows) but not with (b) S. aureus infection. Representative images, scale bar = 20 μm. c Quantification of fluorescence
intensity from the antibodies labeling the subendothelial surface showed that syndecan-1 protein expression during S. aureus infection
was significantly decreased. Data recorded as mean ± SEM and analyzed with Student’s t-test, 4 venules averaged per mouse, n = 4 mice,
***p < 0.0001 compared with LTA
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blood cells, leukocytes, mesothelial cells and fibroblasts
[40]. Thus, the catheter acts as an inflammatory source in
the peritoneum. Host material deposition and leukocyte
recruitment to the catheter lumens were evident in our
study, and the foreign body responses to the catheter
biomaterial were similar between Sdc1-/- mice and wild
type animals.
Previously, we found that syndecan-1 levels do not
change in the parietal peritoneum microcirculation in
response to S. aureus LTA [16], as LTA-challenged mice
had subendothelial syndecan-1 levels that were similar
to the saline-treated animals even though LTA induced
leukocyte recruitment in the peritoneal microcirculation.
This suggests that “sterile” inflammation does not pro-
mote syndecan-1 shedding. However, syndecan-1 shed-
ding was repeatedly shown to be induced by pathogens
[30, 41], such as S. aureus [17], and the microbial com-
ponents that activate syndecan-1 shedding from cellular
membranes were deduced to be S. aureus α- and β-
toxins [42]. These toxins induced syndecan-1 shedding
by activating the host cell’s protein-tyrosine kinase-
dependent shedding mechanisms [42]. In line with these
results, we observed that 4 h after IP injection of a sus-
pension of viable S. aureus cells, syndecan-1 levels in the
subendothelial region of peritoneal venules were signifi-
cantly diminished. Inflammatory cytokines regulate the
expression of syndecan-1 at the protein and mRNA
levels [43]. Therefore, in addition to the pathogen-induced
shedding mechanisms, it is plausible that syndecan-1 ex-
pression in our study was affected by cytokines released in
response to the S. aureus infection. Together, these find-
ings indicate that S. aureus LTA-induced inflammation in
the peritoneum does not model the inflammatory re-
sponses to viable S. aureus cells.
Although we observed dysentery and bacteremia, the
S. aureus infection did not result in severely lowered sys-
temic white blood cell counts that were seen in the cecal
ligation and puncture model of sepsis [44]. Also, we did
not see severely diminished leukocyte recruitment to
peritoneal venules that was observed in the endotoxemia
model of sepsis [16] and the mouse cremaster microcir-
culation during IP S. aureus infection [45]. However, in
the cremaster muscle study, the dose of live S. aureus
cells was higher than used in our study. We observed
greater leukocyte recruitment in acute S. aureus infec-
tion in this study compared with the response to IP in-
jection of S. aureus LTA observed in our previous work.
Also, similar to our previous observations on peritoneal
leukocyte recruitment in response to LTA, lipopolysac-
charide or tumour necrosis factor-α (TNFα), there were
no differences in leukocyte recruitment between wild
type animals and Sdc1-/- mice during infection [16].
Others reported that syndecan-1 deficiency in mice is
associated with increased leukocyte recruitment in
TNFα-stimulated retinal and mesenteric microcircula-
tion [28], naïve cremasteric venules [46], and during ex-
perimental autoimmune encephalomyelitis [47], delayed-
type hypersensitivity response [48], and anti-glomerular
basement membrane nephritis [49]. These different find-
ings emphasize the uniqueness of the molecular mecha-
nisms that regulate leukocyte recruitment in the parietal
peritoneum. However, an important consideration is that
in vitro work indicated that Sdc1-/- monocytes may be
the dominant cell type in the increased leukocyte infil-
trate [50], and higher numbers of monocytes are usually
recruited in vivo after 3 to 4 days following peritonitis
Fig. 9 Syndecan-1 does not modulate leukocyte recruitment to the
parietal peritoneum microcirculation in the early response to S.
aureus infection. Wild type and Sdc1-/- mice were injected
intraperitoneally with 1.8 × 108 colony-forming units of S. aureus. After
4 h, the microcirculation of the parietal peritoneum was imaged with
intravital microscopy. The numbers of (a) rolling and (b) adherent
leukocytes in the peritoneal venules, as well as the number of (c)
extravascular leukocytes, were quantified. S. aureus infection significantly
increased the number of adherent and extravascular leukocytes
compared with saline controls. However, there were no significant
differences in leukocyte recruitment between the wild type and Sdc1-/-
mice. Data recorded as mean ± SEM and analyzed with ANOVA with
Bonferroni correction, 4–6 venules averaged per count, n= 4 mice,
**p< 0.001 and ***p< 0.0001 compared with saline
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[51], which may explain our observations that Sdc1-/- mice
do not have elevated leukocyte recruitment in the early re-
sponse to infection. Thus, it should be emphasized that
our conclusions regarding the effects of syndecan-1 on in-
fection and inflammation are only relevant to the early
acute inflammatory responses after 4 h of infection.
Conclusions
Our study demonstrated that syndecan-1 deficiency does
not impact histopathologic deterioration of the peritoneal
layer in a mouse model of PD. Thus, despite the clinical
relevance of syndecan-1 in the prognosis of diseases such
as multiple myeloma [52], and sepsis [53], syndecan-1
does not appear to be important in PD-induced pathology.
We did, however, find that syndecan-1 is important for
limiting acute peritoneal S. aureus infection, which may
have implications for incidence of peritonitis and infections
in PD patients. Alongside current literature, the seemingly
contrasting observations emphasize that syndecan-1 func-
tions are cell- and tissue-specific and call for a careful
comparison between experimental models. Furthermore,
future research should dissect the peritoneal responses to S.
aureus at longer infection time points during syndecan-1
deficiency and compare these responses with other major
pathogens that cause peritonitis in PD in order to fully
understand the role of syndecan-1 in injury, infection and
inflammation.
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